Close
Help
Need Help?



Healthy Aging & Clinical Care in the Elderly Now on JournalTOCs and 8 Other Directories

Posted Wed, Nov, 14,2012

Libertas is pleased to announce that Healthy Aging & Clinical Care in the Elderly is now included in the JournalTOCs (Journal Tables of Contents) directory and content is available through the website now.JournalTOCs contains metadata from over 17,000 journals collected from almost 1,000 international publishers. The directory is free for anyone to browse the latest news, articles, and develop...

Continue Reading →

Open Access Visibility Statistics for Primary Prevention Insights

Posted Wed, Nov, 14,2012

Articles published in open access journals like Primary Prevention Insights are likely to receive more citations and a higher level of visibility than articles published in restricted access journals.Libertas’ goal is to maximize visibility for all articles published in Primary Prevention Insights and articles in the journal have been viewed more than 13,193 times since 2008. In addition to ...

Continue Reading →

Clinical Medicine Insights: Trauma and Intensive Medicine Added to Gale Health Reference Centre

Posted Wed, Nov, 14,2012

Libertas is pleased to announce that Clinical Medicine Insights: Trauma and Intensive Medicine has now been added to Gale's Health Reference Centre database.GALE operates more than 600 databases, including the popular Info Trac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Clinical Medicine Insights: Trauma and Intensive Me...

Continue Reading →

New Particle Physics Insights Call for Papers

Posted Wed, Nov, 14,2012

The Editor in Chief, Dr Hanna Moussa, is pleased to announce a new call for papers for Particle Physics Insights. Submissions are being accepted now.All authors who submit their manuscripts to Libertas will benefit from:Professional Manuscript EditingConvenient 3-step online manuscript submissionNo space restrictions or color figure chargesOptional immediate publicationInclusion of your article in...

Continue Reading →

Posted in: Calls for Papers

Drug Target Insights now added To Chinese Electronic Periodical Services

Posted Wed, Nov, 14,2012

Libertas is pleased to announce that Drug Target Insights is now indexed by the Chinese Electronic Periodical Services. (CEPS) and journal content will be available there soon.CEPS is operated by Airitri Inc., and in 2005 & 2007 won the ‘Best Subsidized Digital Publication award’ from the News Bureau of Executive Yuan of Taiwan.Researchers and academics can search CEPS and download...

Continue Reading →

What Peer Reviewers Say

Posted Wed, Nov, 14,2012

Every paper published in Libertas journals is peer reviewed by two highly qualified peer reviewers.  After each peer review is completed we ask the reviewers for their feedback on our peer review process.  This helps us to ensure that we're consistently achieving our goal of providing a high quality peer review process.  We asked reviewers to rate their experience in five areas ...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
It's been a great experience publishing in Clinical Medicine Insights: Therapeutics. I'm really impressed with the high quality, professional and constructive of peer review in the short time-frame. The editorial team is very helpful and I always received quick answers when I had questions. I am glad to have worked with Libertas Academica and I highly recommend publishing in Clinical Medicine Insights: Therapeutics.
Dr Thanyanan Reungwetwattana (Mayo Clinic, Rochester, MN, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results